Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Opioid-Related Disorders 1Opioid-Induced Constipation 1Neoplasms 1Constipation 1

Interventions

Standard of Care 2salicylhydroxamic acid 1methylnaltrexone 1acetaminophen, codeine drug combination 1X-Rays 1Ultrasonic Waves 1Tramadol 1Tirzepatide 1Therapeutics 1Sublocade 1Radiography, Abdominal 1Psilocybin 1Olanzapine 1Morphine 1Midazolam 1Methadone 1Medical Marijuana 1Lidocaine 1Hematologic Tests 1Educational Status 1Dosage Forms 1Capsules 1Buprenorphine, Naloxone Drug Combination 1Buprenorphine 1Blood Specimen Collection 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Opioid-Related Disorders × methylnaltrexone × Clear all
NCT01004393 2016-02-02

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

University of Vermont

Phase 2 Completed
12 enrolled 10 charts
Other

Constipation, Opioid-Related Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡